2023
DOI: 10.1016/j.antiviral.2023.105583
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a novel acylthiourea-based potent broad-spectrum inhibitor for enterovirus 3D polymerase in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 43 publications
0
6
0
Order By: Relevance
“…The design strategy for hydrophobically tagged small molecules is shown in Figure . In the previous study, we identified hit compounds with an acyl thiourea scaffold that exerted anti-influenza activity by inhibiting RdRp function. , To facilitate the novel design of HyT degraders, following numerous rounds of structure–activity relationship (SAR) studies, we selected the potent and most suitable 11 as a POI ligand with potent antiviral activity against A/PR/8/H1N1 (EC 50 = 0.024 ± 0.005 μM). Our studies revealed that alteration of the tert -butyl group on the left side of the acyl thiourea backbone was often accompanied by a decrease in anti-influenza virus activity, while modification of the right amino group was tolerated.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The design strategy for hydrophobically tagged small molecules is shown in Figure . In the previous study, we identified hit compounds with an acyl thiourea scaffold that exerted anti-influenza activity by inhibiting RdRp function. , To facilitate the novel design of HyT degraders, following numerous rounds of structure–activity relationship (SAR) studies, we selected the potent and most suitable 11 as a POI ligand with potent antiviral activity against A/PR/8/H1N1 (EC 50 = 0.024 ± 0.005 μM). Our studies revealed that alteration of the tert -butyl group on the left side of the acyl thiourea backbone was often accompanied by a decrease in anti-influenza virus activity, while modification of the right amino group was tolerated.…”
Section: Resultsmentioning
confidence: 99%
“…(S)-2-Amino-N (30). tert-Butyl 8-bromooctanoate 26 (2.0 g, 7.17 mmol) was added to the solution of 27 (2.50 g, 5.97 mmol) in MeCN (40 mL), and then K 2 CO 3 (2.47 g, 17.91 mmol) was added and the mixture was stirred at 80 °C for 12 h. The reaction mixture was quenched using water and extracted with ethyl acetate (50 mL × 3).…”
Section: Tert-butyl (R)-(1-((4-(3-(4-(tert-butyl)benzoyl)thioureido)p...mentioning
confidence: 99%
“…The key role of 3D pol in viral replication and its structural and sequence conservation make it a promising target for specific antiviral therapeutics ( 19 , 31 , 226 ). Several compounds that bind to 3D pol active sites to block viral replication have been identified, which markedly reduce the synthesis of viral RNA by interacting with or occupying the 3D pol active sites to inhibit enzyme function ( 227 229 ). Therefore, further elucidating the structures and molecular functions of 3D pol is valuable and could be useful for future antiviral treatment of picornaviruses.…”
Section: Discussionmentioning
confidence: 99%
“…Tenovin-1 derivative AcTU showed broad-spectrum resistance against enteroviruses such as EV-A71, EV-D68, CVA16, CVA21, and CVB1. Mechanistically, AcTU inhibited viral replication by targeting 3D pol , and excitingly, in vivo experiments demonstrated that oral administration of AcTU at 0.6 mg/kg/d to mice was highly protective against lethal EV-A71 attack [ 139 ]. Jeong et al found 2-amino-4-arylthiazole targets FMDV 3D pol by high throughput screening (HTS) adapting fluorescence polarization (FP), and in vitro evaluations of its derivatives 20i and 24a showed more effective inhibition of FMDV [ 140 ].…”
Section: Drugs Acting On 3d Polmentioning
confidence: 99%